EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma

Takuma Hayashi iD, Ikuo Konishi iD

Journal of Clinical Medicine Research · 2023-02 · 15 (2) · 68-75

DOI: 10.14740/jocmr4853 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine Research, 2023-02. Verfasst von Takuma Hayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Hospital Organization Kyoto Medical Center, Fukakusa Mukaihata-cho, Kyoto 612-8555, Japan. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BRCAHBOCHigh-grade serous carcinomaOvarian cancerPrevention

Autor:innen und Institutionen

  • National Hospital Organization Kyoto Medical Center, Fukakusa Mukaihata-cho, Kyoto 612-8555, Japan.
  • Kyoto University, Graduate School of Medicine, Sakyo-ku, Kyoto 606-8507, Japan.

ORCID-Profile: Takuma Hayashi, Ikuo Konishi

Zitieren

APA

Hayashi, T., & Konishi, I. (2023). Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma. Journal of Clinical Medicine Research, 15(2), 68-75. https://doi.org/10.14740/jocmr4853

Vancouver

Hayashi T, Konishi I. Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma. Journal of Clinical Medicine Research. 2023;15(2):68-75. doi:10.14740/jocmr4853

BibTeX
@article{Hayashi2023,
  author = {Hayashi, Takuma and Konishi, Ikuo},
  title = {Molecular Histopathology for Establishing Diagnostic Method and Clinical Therapy for Ovarian Carcinoma},
  journal = {Journal of Clinical Medicine Research},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {68--75},
  doi = {10.14740/jocmr4853}
}
Kostenlos starten →